Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
- Conditions
- Lung Cancer
- Registration Number
- NCT00899405
- Lead Sponsor
- University of California, Davis
- Brief Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.
- Detailed Description
OBJECTIVES:
* Examine the mutational status of the EGFR pathway in tumor and blood samples from patients with lung cancer.
* Correlate the EGFR pathway mutations in these samples with clinical outcomes of these patients.
OUTLINE: Archived tumor tissue and blood samples are analyzed via PCR to detect EGFR pathway mutations in DNA.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 800
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mutational status of the EGFR pathway up to 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of California Davis Cancer Center
🇺🇸Sacramento, California, United States